Guidance for the public, FDA advisory committee members, and FDA staff : public availability of advisory committee members' financial interest information and waivers.

Guidance for industry and FDA staff : application user fees for combination products.
Published: (2005)

FDA advisory committees : process for recruiting members and evaluating potential conflicts of interest : report to congressional requesters.
Published: (2008)

Guidance for industry, FDA staff, and FDA-accredited third parties.
Published: (2009)

Guidance for FDA staff and industry : marketed unapproved drugs, compliance policy guide.
Published: (2006)

Guidance for industry and FDA staff : devices used to process human cells, tissues, and cellular and tissue-based products (HCT/Ps).
Published: (2007)

Guidance for industry : financial disclosure by clinical investigators.
Published: (2001)

FDA Advisory Committees : Process for Recruiting Members and Evaluating Potential Conflicts of Interest.
Published: (2008)

Guidance for FDA reviewers : premarket notification submissions for blood and plasma warmers.
Published: (2001)

Guidance for industry and FDA staff : how to write a request for designation (RFD).
Published: (2005)

Draft guidance for industry and FDA staff : technical considerations for pen, jet, and related injectors intended for use with drugs and biological products.
Published: (2009)

Guidance for FDA reviewers : premarket notification submissions for empty containers for the collection and processing of blood and blood components.
Published: (2001)

The open public hearing : FDA advisory committee meetings.
Published: (2004)

Guidance for industry and FDA : current good manufacturing practice for combination products.
Published: (2004)

Guidance for industry and FDA staff : submission and resolution of formal disputes regarding the timeliness of premarket review of a combination product.
Published: (2004)

Guidance for FDA reviewers : premarket notification submissions for transfer sets (excluding sterile connecting sets).
Published: (2001)

Waivers of the Small Business Administration's nonmanufacturer rule have limited effect.
by: Woods, William T.
Published: (2002)

FDA Advisory Committee Conflict of Interest.
Published: (2009)

FDA Advisory Committee Conflict of Interest.
Published: (2007)

Guidance for the public, FDA advisory committee members, and FDA staff on procedures for determining conflict of interest and eligibility for participation in FDA advisory committees.
Published: (2008)

Backgrounder for the 2004 FDA/EPA consumer advisory : what you need to know about mercury in fish and shellfish.
Published: (2004)

The FDA follies /
by: Burkholz, Herbert, 1932-2006
Published: (1994)

Oversight of the 1946 Federal Regulation of Lobbying Act : hearings before the Committee on Governmental Affairs, United States Senate, Ninety-eighth Congress, first session, November 15 and 16, 1983.
Published: (1984)

Waiver of patent and trademark requirements in certain emergencies : report (to accompany H.R. 4742) (including cost estimate of the Congressional Budget Office).
Published: (2006)

FDA User Fees : Advancing Public Health.
Published: (2011)

FDA cautions against using unapproved IUD's.
Published: (2010)

Department of Defense's waiver of competitive prototyping requirement for the Army's Armored Multi-purpose Vehicle program /
by: Sullivan, Michael J.
Published: (2014)

FDA checkup : drug development and manufacturing challenges : hearing before the Subcommittee on Energy Policy, Health Care and Entitlements of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Thirteenth Congress, first session, December 12, 2013.
Published: (2014)

Waiver of Tourist Visas : hearings before the United States House Committee on the Judiciary, Subcommittee No. 1 (Judiciary), Ninetieth Congress, second session, on Mar. 21, 1968.
Published: (1968)

Waiver of claims : hearing, Ninety-first Congress, first session on H.R. 7363 ... May 21, 1969.
Published: (1970)

FDA's role in protecting the public health : examining FDA's review of safety and efficacy concerns in anti-depressant use by children : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, September 23, 2004.
Published: (2005)

FDA's role in protecting the public health : examining FDA's review of safety and efficacy concerns in anti-depressant use by children : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, September 23, 2004.
Published: (2005)

The National Bioethics Advisory Commission : contributing to public policy /
by: Eiseman, Elisa
Published: (2003)

The FDA's regulation of silicone breast implants : a staff report /
Published: (1993)

Current FDA activities related to the Listeria monocytogenes action plan.
Published: (2008)

FDA and industry actions on premarket approval applications (PMAs), effect on FDA review clock and goals.
Published: (2008)

Guidance for industry : FDA export certificates.
Published: (2005)